Back to the list
Congress: ECR25
Poster Number: C-12663
Type: Poster: EPOS Radiologist (scientific)
DOI: 10.26044/ecr2025/C-12663
Authorblock: M. D. C. Rodríguez Calvo1, M. I. Martínez León2, L. M. M. Kubandt2, M. A. Pérez Benítez3, I. Hidalgo Hurtado4, C. Madrid Lopez5, C. Osuna Otal5, L. Muñoz Olmo6; 1El Puerto de Santa María/ES, 2MALAGA/ES, 3Conil de la Frontera/ES, 4Jerez de la Frotnera/ES, 5Cadiz/ES, 6San Fernando/ES
Disclosures:
María Del Camino Rodríguez Calvo: Nothing to disclose
María Isabel Martínez León: Nothing to disclose
Leona María Manzano Kubandt: Nothing to disclose
Manuel Alejandro Pérez Benítez: Nothing to disclose
Ildefonso Hidalgo Hurtado: Nothing to disclose
Cesar Madrid Lopez: Nothing to disclose
Cristina Osuna Otal: Nothing to disclose
Luis Muñoz Olmo: Nothing to disclose
Keywords: Musculoskeletal system, Neuroradiology peripheral nerve, Paediatric, CT, MR, Complications, Image compression, Radiation therapy / Oncology, Cancer, Metastases, Neoplasia
References
  1. Wang MX, Dillman JR, Guccione J, Habiba A, Maher M, Kamel S, Panse PM, Jensen CT, Elsayes KM. Neurofibromatosis from Head to Toe: What the Radiologist Needs to Know. Radiographics. 2022;42:1123-1144. doi: 10.1148/rg.210235. Epub 2022 Jun 24. PMID: 35749292.
  2. Panigrahi S, Mishra SS, Das S, Dhir MK. Primary malignant peripheral nerve sheath tumor at unusual location. J Neurosci Rural Pract. 2013;S83-6. doi: 10.4103/0976-3147.116480. 
  3. Abbas O, Bhawan J. Cutaneous plexiform lesions. J Cutan Pathol. 2010;37:613-23. doi: 10.1111/j.1600-0560.2010.01529.
  4. Carton C, Evans DG, Blanco I, Friedrich RE, Ferner RE, Farschtschi S, Salvador H, Azizi AA, Mautner V, Röhl C, Peltonen S, Stivaros S, Legius E, Oostenbrink R; ERN GENTURIS NF1 Tumour Management Guideline Group. ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1. EClinicalMedicine. 2023;56:101818. doi: 10.1016/j.eclinm.2022.101818.
  5. Fisher MJ, Blakeley JO, Weiss BD, Dombi E, Ahlawat S, Akshintala S, Belzberg AJ, Bornhorst M, Bredella MA, Cai W, Ferner RE, Gross AM, Harris GJ, Listernick R, Ly I, Martin S, Mautner VF, Salamon JM, Salerno KE, Spinner RJ, Staedtke V, Ullrich NJ, Upadhyaya M, Wolters PL, Yohay K, Widemann BC. Management of neurofibromatosis type 1-associated plexiform neurofibromas. Neuro Oncol. 2022;24(11):1827-1844. doi: 10.1093/neuonc/noac146.
  6. Prudner BC, Ball T, Rathore R, Hirbe AC. Diagnosis and management of malignant peripheral nerve sheath tumors: Current practice and future perspectives. Neurooncol Adv. 2019;2(Suppl 1). doi: 10.1093/noajnl/vdz047.
  7. Prada CE, Rangwala FA, Martin LJ, Lovell AM, Saal HM, Schorry EK, Hopkin RJ. Pediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1. J Pediatr. 2012;160(3):461-7. doi: 10.1016/j.jpeds.2011.08.051.
  8. Gross AM, Dombi E, Wolters PL, Baldwin A, Dufek A, Herrera K, Martin S, Derdak J, Heisey KS, Whitcomb PM, Steinberg SM, Venzon DJ, Fisher MJ, Kim A, Bornhorst M, Weiss BD, Blakeley JO, Smith MA, Widemann BC. Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas. Neuro Oncol. 2023;25(10):1883-1894. doi.org/10.1093/neuonc/noad086.
GALLERY